Our company was one of the first spin-offs of the University of Liège, originally founded as Centre d’Investigation du Métabolisme de l’Os et du CArtilage (CIMOCA SA), later Société Universitaire de Promotion de la REcherche MEdicale (SUPREME SA.).

Over the last years, we have been working with the largest pharmaceutical companies, around the world, to test biochemical markers, in various body fluids, in most of the major phase II and phase III clinical trials, conducted in osteoporosis, osteoarthritis, rheumatoid arthritis and more recently sarcopenia and frailty. We now work in close partnership with the certified and renown Laboratory of Clinical Chemistry of the University Hospital of Liège (128-MED/ISO15189:2012).

Whereas we are considered as one of the most reliable and accurate central facilities for testing of biological fluids, our rates remain highly competitive compared to most major competitors. Our expertise in dealing with regulatory authorities, in various parts of the world, offers an added value to our services.